PHI with Persistent truncus arteriosus
How does this condition affect your private health insurance?
Persistent Truncus Arteriosus (PTA) is a rare, severe congenital heart defect where a single great artery arises from both ventricles, replacing the normal aorta and pulmonary artery. This single vessel carries mixed blood to the body and lungs. A large ventricular septal defect (VSD) is almost always present. This results in excessive blood flow to the lungs, leading to early onset heart failure, pulmonary hypertension, and cyanosis. Without prompt surgical correction, typically within the first weeks of life, the condition is usually fatal due to progressive heart failure and irreversible pulmonary vascular disease. Lifelong cardiac follow-up is essential post-surgery.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
From birth; symptoms manifest within days to weeks.
Duration of Illness (Lifetime)
Life-long, requiring chronic management and follow-up after surgical correction; rapidly fatal if untreated.
Cost of Treatment (Initial)
Very high, involving complex cardiac surgery and intensive care (e.g., hundreds of thousands of USD).
Cost of Treatment (Lifetime)
High, including initial surgery, lifelong specialist follow-ups, potential repeat surgeries, and management of residual issues.
Mortality Rate
Very high (80-90% within the first year) without surgical intervention; significantly reduced with timely surgery (5-15% perioperative mortality), but long-term risks remain.
Risk of Secondary Damages
High, including chronic pulmonary hypertension, heart failure, infective endocarditis, and need for repeat surgical interventions (e.g., conduit replacement).
Probability of Full Recovery
Low, as lifelong cardiological follow-up and potential for re-interventions (e.g., conduit replacement) are usually necessary; a 'cure' without any long-term consequences is rare.
Underlying Disease Risk
Moderate to high (e.g., 15-30%), especially chromosomal abnormalities like DiGeorge syndrome (22q11.2 deletion) and other congenital anomalies.